Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Breast Cancer Metastatic × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Other neoplasm 1

Conditions

Precancerous Conditions 32 Lymphoma 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Lymphoma, Non-Hodgkin 12 Lymphoma, Mantle-Cell 12 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma, Follicular 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Leukemia 12 Burkitt Lymphoma 12 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Neoplasms, Plasma Cell 11 Multiple Myeloma 11 Monoclonal Gammopathy of Undetermined Significance 11 Lymphoma, B-Cell, Marginal Zone 11 Leukemia, Large Granular Lymphocytic 11 Leukemia, Hairy Cell 11 Immunoglobulin Light-chain Amyloidosis 11 Waldenstrom Macroglobulinemia 10 Thrombocythemia, Essential 10 Primary Myelofibrosis 10 Myeloproliferative Disorders 10 Myelodysplastic Syndromes 10 Leukemia, Myeloid, Acute 10 Immunoblastic Lymphadenopathy 10 Hodgkin Disease 10 Polycythemia Vera 9 Lymphoma, Large-Cell, Anaplastic 9 Leukemia, Prolymphocytic 9

Interventions

palbociclib 1 Rogaratinib 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04483505 2023-12-28

ROGABREAST

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1 Completed

BreastOther neoplasm

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡